Owner & Managing Director

• For Investors: assessment of potential investments, preparing Q&As and giving independent opinions to specific questions that the investors have to validate the candidates.
• For Startups: assessment of lifecycle strategy, TPPs, calculating a business case and acting as commercial sparing partner in key phases, e.g. Series A, Bs etc.
• For Big & Small Pharma: providing launch concepts, access-, strategic- and go to market-plans.
• For High Confidentiality: acts as independent expert at the international court of arbitration and other high confidentiality projects.
• For all / freelancing: happy to take temporary assignments where bottlenecks exist for global, regional and local roles, provided capacity allows.

Main expertise is the global, European and Swiss market, with support for launches in Germany.

Deeper experience and established network in neurosciences (MS, Alzheimers, Parkinsons, Epilepsy), oncology (solid and hemato-oncology), hematology, rheumatology, cardiology, metabolism, and biosimilars; routes of administration include orals, inhalers, pens, infusions, injections.

• Led global marketing as designated cross-functional launch leader for Multiple Sclerosis (2019-2021), Alzheimer’s Disease (2021-2022) and rare disease Oncology/Hematology (2023-2024): driving strategic projects, implementing outcome-based planning, agile methodologies, co-creating go to market models, planning and executing omnichannel and digital marketing, social media marketing, launch of subcutaneous applications/pens, leading global work-product teams in close cooperation with teams in the USA, China, Japan and key European countries.
• Tripled launch performance from 9% to 27% patient share within six months using customer insights and ‘rational choice’ science; repositioned a global brand with a new campaign shifting perception of a targeted segment; introduced digital customer interfaces successfully post-pandemic; saved hundreds of thousands CHF by internalizing processes and services through cocreation.

• Led launch efforts in 23 European countries and the Swiss Biosimilar Task Force to mitigate patent cliff risk for biologic antibodies: set up and led a cross-functional task force shaping Swiss stakeholder engagement, public affairs, policy and lobbying, negotiating within Interpharma and science industries, coauthoring whitepapers, managing media relations, public speaking and organizing launch reviews.
• Achieved optimal regulatory framework through negotiations with pharma associations and Swissmedic; led an award-winning biosimilar awareness campaign and PR; presented task force outcomes to the Roche Board of Directors and executive committee; ensured crossfertilization and launch excellence across all countries by preparing over 30 launch reviews and training sessions.

• Managed primary care customers in the Greater Zürich area: organized sales calls and executed sales excellence with general practitioners, cardiologists, nephrologists and gynecologists for products including Xenical, Dilatrend, Torem, Pegasys, Elevit and Bonviva.
• Consistently overdelivered on sales targets by double digits through active listening, consultative selling and optimized follow-up management; achieved five calls per day and won the national sales award multiple times with ongoing senior management support.

• Gained experience in the US market during a marketing internship at the maxillofacial department in West Chester, PA: worked in cross-functional teams, improved English fluency, engaged in intercultural communication, supported competitive intelligence, medtech marketing, project management, MS Excel, MS PowerPoint, device testing and HTML programming.
• Launched an internal website with HTML and a database standard for the firm and presented it department-wide to full satisfaction of superiors.